Celyad Oncology SA (CLYYF)
0.315
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Celyad Oncology Total Liabilities (Quarterly): 12.13M for June 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 12.13M |
| June 30, 2022 | 33.94M |
| March 31, 2022 | 36.52M |
| December 31, 2021 | 41.10M |
| September 30, 2021 | 45.41M |
| June 30, 2021 | 45.02M |
| March 31, 2021 | 43.12M |
| December 31, 2020 | 43.16M |
| June 30, 2020 | 51.11M |
| December 31, 2019 | 49.53M |
| June 30, 2019 | 45.98M |
| June 30, 2019 | 45.98M |
| December 31, 2018 | 44.28M |
| June 30, 2018 | 42.05M |
| June 30, 2018 | 42.05M |
| December 31, 2017 | 36.10M |
| Date | Value |
|---|---|
| June 30, 2017 | 49.24M |
| June 30, 2017 | 49.24M |
| December 31, 2016 | 50.66M |
| June 30, 2016 | 48.24M |
| June 30, 2016 | 48.24M |
| December 31, 2015 | 52.54M |
| June 30, 2015 | 65.51M |
| June 30, 2015 | 65.51M |
| December 31, 2014 | 21.03M |
| June 30, 2014 | 22.00M |
| June 30, 2014 | 22.00M |
| December 31, 2013 | 21.39M |
| June 30, 2013 | 21.07M |
| June 30, 2013 | 21.07M |
| December 31, 2012 | 19.50M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
12.13M
Minimum
Jun 2023
51.11M
Maximum
Jun 2020
41.08M
Average
44.09M
Median
Total Liabilities (Quarterly) Benchmarks
| Galapagos NV | 1.584B |
| UCB SA | 7.256B |
| Mithra Pharmaceuticals SA | 416.74M |
| Nyxoah SA | 27.88M |
| MDxHealth SA | 122.72M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.23M |
| Shareholders Equity (Quarterly) | 1.107M |
| Current Ratio | 1.263 |
| Net Debt Paydown Yield | 1.18% |